The Microalbuminuria Education Medication and Optimisation (MEMO) study: Four years follow up of multifactorial intervention in high risk individuals with type 2 diabetes.
posted on 2020-11-05, 13:51authored byW Crasto, A Morrison, L Gray, E John, J Jarvis, J Brela, K Khunti, J Troughton, I Lawrence, P McNally, M Davies
Aims
The Microalbuminuria Education Medication and Optimisation (MEMO) study, revealed improved cardiovascular risk and glycaemic control with 18 months of intensive multifactorial intervention in high‐risk people with type 2 diabetes, without any increase in severe hypoglycaemia. Our aim was to assess longer‐term outcomes at 4‐year follow‐up in these participants.
Methods
Some 189 individuals with type 2 diabetes and microalbuminuria were recruited from a multi‐ethnic population in Leicestershire, UK. The intervention group (n = 95) received multifactorial intervention with self‐management education, and the control group (n = 94) received usual care. The primary outcome was change in HbA1c, and secondary outcomes were blood pressure (BP), cholesterol, microalbuminuria, estimated GFR, cardiovascular risk scores and major adverse cardiovascular events.
Results
Some 130 participants (68.7%), mean (sd) age 60.8 (10.4) years, duration of diabetes 11.5 (9.7) years, completed 4 years of follow‐up. Mean change [95% confidence intervals (CI)] in HbA1c over 4 years was greater with intensive intervention compared with control (−3 mmol/mol, 95% CI −4.95,−1.11; −0.4%, 95% CI −0.67,−0.15; P = 0.002). Significant improvements over the 4 years were also seen in systolic BP (−7.3 mmHg, 95% CI −11.1, −3.5; P < 0.001), diastolic BP (−2.9 mmHg, 95% CI −5.4, −0.3; P = 0.026), cholesterol (−0.3 mmol/l, 95% CI −0.52,−0.12; P = 0.002), and 10‐year coronary heart disease (−5.3, 95% CI −8.2,−2.3; P < 0.001) and stroke risk (−4.4, 95% CI −7.5, −1.3; P < 0.001).
Conclusion
Multifactorial intervention with structured diabetes self‐management education compared with usual diabetes care has benefits for cardio‐metabolic risk factor profile. There was no increase in severe hypoglycaemia and cardiovascular mortality despite intensive glycaemic control, although the study was not powered to assess these outcomes.
Funding
We thank the National Institute for Health Research Collaboration for Leadership in Applied
Health Research and Care—East Midlands (NIHR CLAHRC–EM), the Leicester Clinical Trials
Unit, and the NIHR Leicester Biomedical Research Centre, which is a partnership between
University Hospitals of Leicester NHS Trust and the University of Leicester.
History
Citation
Diabetic Medicine, Volume 37, Issue 2, February 2020, Pages 286-297
Author affiliation
/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Health Sciences
The file associated with this record is under embargo until 12 months after publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.